Market Access, Pricing, Value and Evidence


World Pharma Pricing and Market Access is Europe’s leading pricing, access and evidence congress featuring over 200 speakers, multiple streams and over several hundred senior attendees.

Our 2019 edition we will be moving to Amsterdam and will have even more streams and valuable content featured. Next year there will be a greater focus on the latest developments taking place in pricing, market and evidence, including the role of big data to support evidence generation and RWD.

Furthermore, there will be more patient involvement in the form of presentations and roundtable discussions including the opportunity to deliver poster sessions.

We will also be revamping the format for 2019. The format for this congress will build upon what was achieved in 2018.

With additional streams, roundtables and speaking slots. The new streams will be focusing on innovative practices taking place in evidence, pricing and market access as well as expanding upon developments taking place in rare diseases, advanced therapies and emerging markets.

Furthermore, we will be growing the number of industry leaders from across pharma, HTAs, payers and patient organisations.

We are already working with a number of solution providers regarding sponsorship for the 2019 event. If you believe you have a message that you want to share with our 400+ senior attendees, then get in touch today to discuss what options are available.

This year promises to be the most exciting World Pharma Pricing and Market Access event yet. Don’t miss out on your chance to be involved and I look forward to meeting you next March.


“Good conference, well organized, well attended and a great learning experience overall.”

Director, Global Health and Life Sciences, SAS